Status: Recruiting
The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.
To evaluate the efficacy and safety of Neovasculgen in interstitial cystitis and the prevention of secondary bladder shrinkage with a decrease in its volume.
Participants needed: 180
Trial details
Phase: Phase 2, Phase 3Age: 18-65Biological sex: FemaleType: InterventionalSponsor: JSC NextGenUpdated: Feb 5, 2026Locations: 1
Eligibility criteria
Written informed consent prior to any study-related procedures. [+6]
Any condition that prevents intravesical administration of medications. [+14]